European prevalence of Epidermal Growth Factor Receptor (EGFR) mutations in patients with Non-small Cell Lung Cancer (NSCLC): A meta-analysis

被引：0
|
作者：
Haentschel, M. [1 ]
Kambartel, K. [2 ]
Melosky, B. [3 ]
Cappuzzo, F. [4 ]
Bennetts, M. [5 ]
Nickens, D. J. [6 ]
Brinkmann, J. [7 ]
Kayser, A. [7 ]
Moran, M. [7 ]
Laack, E. [8 ]
机构：
[1] Univ Hosp Tubingen, Tubingen, Germany
[2] Krankenhaus Bethanien, Moers, Germany
[3] Univ British Columbia, BC Canc, Vancouver, BC, Canada
[4] AUSL Romagna, Ravenna, Italy
[5] Pfizer R&D UK Ltd, Sandwich, Kent, England
[6] Pfizer Inc, La Jolla, CA USA
[7] Pfizer Pharma GmbH, Berlin, Germany
[8] Hamatoonkol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
135
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [1] Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis
    Melosky, B.
    Laack, E.
    Kambartel, K.
    Haentschel, M.
    Bennetts, M.
    Nickens, D.
    Brinkmann, J.
    Kayser, A.
    Moran, M.
    Cappuzzo, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S449 - S449
  • [2] Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
    Melosky, Barbara
    Kambartel, Kato
    Haentschel, Maik
    Bennetts, Margherita
    Nickens, Dana J.
    Brinkmann, Julia
    Kayser, Antonin
    Moran, Michael
    Cappuzzo, Federico
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2022, 26 (01) : 7 - 18
  • [3] Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
    Barbara Melosky
    Kato Kambartel
    Maik Häntschel
    Margherita Bennetts
    Dana J. Nickens
    Julia Brinkmann
    Antonin Kayser
    Michael Moran
    Federico Cappuzzo
    [J]. Molecular Diagnosis & Therapy, 2022, 26 : 7 - 18
  • [4] Mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC).
    Sonobe, M
    Katakura, H
    Adachi, T
    Wada, H
    Tanaka, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [5] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    [J]. APMIS, 2012, 120 : 14 - 14
  • [6] Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Zhou, Yongchun
    Yang, Yanlong
    Yang, Chenggang
    Chen, Yunlan
    Yang, Changshao
    Du, Yaxi
    Zhao, Guangqiang
    Guo, Yinjin
    Ye, Lianhua
    Huang, Yunchao
    [J]. ONCOTARGET, 2017, 8 (09) : 15023 - 15033
  • [7] Epidermal Growth Factor Receptor (EGFR) mutation testing in non-small cell lung cancer (NSCLC) patients
    Eaton, Helen
    Dutton, L.
    Wallace, A. J.
    Howard, E.
    Gaunt, L.
    Blackhall, F.
    Newman, W.
    [J]. JOURNAL OF MEDICAL GENETICS, 2011, 48 : S72 - S72
  • [8] Epidermal Growth Factor Receptor (EGFR) Mutation Testing in non-small cell lung cancer (NSCLC) patients
    Wallace, Andrew
    Howard, E.
    Dutton, L.
    Elles, R. G.
    Newman, W.
    [J]. JOURNAL OF MEDICAL GENETICS, 2010, 47 : S66 - S66
  • [9] Prevalence of epidermal growth factor receptor (EGFR) mutation in an Ecuadorian population with non-small cell lung cancer (NSCLC).
    Rivas, Carmen
    Martinez, Luis A.
    Eduardo Teran, Enrique
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    [J]. SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
12345